Description
An active metabolite of atorvastatin; formed from atorvastatin by CYP3A4; inhibits lipid hydroperoxide formation and copper sulfate-induced TBARS formation in DLPC vesicles and human LDL, respectively, in a concentration-dependent manner; reduces OGD-induced cell death in primary rat cortical neurons and increases phosphorylation of CREB in GABAergic neurons at 600 nM following OGD
Formal name: (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-4-[[(2-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrole-1-heptanoic acid, calcium salt (2:1)
Synonyms: o-hydroxy Atorvastatin|ortho-hydroxy Atorvastatin|BMS 243887-01|PD 152873
Molecular weight: 593.7
CAS: 265989-46-6
Purity: ≥95%
Formulation: A solid